Collectively, loss of LKB1 not only alters intracellular signaling and cellular functions but also modifies the extracellular microenvironment, enabling cancer cells to evade cancer immunosurveillance thus promoting intrinsic resistance to immunotherapy. Here, STK11 is linked to cancer.